New pill combo aims to tame tough bone marrow cancer
Disease control
Recruiting now
This early-stage study tests an oral combination of tetrahydrouridine and decitabine in 20 adults with myelodysplastic syndromes (MDS) that returned or didn't respond to prior therapy. The main goals are to check safety and see if the drug improves blood cell counts and reduces h…
Phase: PHASE1 • Sponsor: Treebough Therapies • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC